Navigation Links
Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
Date:5/30/2012

LOS ANGELES, May 30, 2012 /PRNewswire/ -- Today, at the 52nd annual New Clinical Drug Evaluation Unit (NCDEU) Conference in Arizona, Ian Cook, M.D., Professor of Psychiatry at the University of California, Los Angeles (UCLA) and a Senior Medical Advisor to NeuroSigma, Inc., presented the results from the first 6-subject cohort of a 10-subject Phase I open-label clinical trial studying the effects of external trigeminal nerve stimulation (eTNS™) on Post-Traumatic Stress Disorder (PTSD) and depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy.  The trial is being conducted at UCLA and is funded by NeuroSigma.  Mean decreases in PTSD measures of 36% and depression measures of over 50% were reported.

The study was conducted over an 8-week period and followed similarly designed eTNS trials conducted at UCLA, in which promising results were generated in treating both major depression and epilepsy.  Subjects had a mean age of 54 with a median of 28 years since traumatic exposure and suffered from both PTSD and MDD.  Current episodes were required to be of at least four months in duration, with non-response to at least one antidepressant.  In this outpatient trial, subjects placed stimulating eTNS electrodes on their foreheads for approximately eight hours each night while asleep, and the severity of PTSD and depression symptoms was measured every two weeks using standard recognized rating scales. 

"These findings are very encouraging," said Dr. Cook.  "The combination of depression and an anxiety disorder, like PTSD, is usually difficult to treat effectively.  The participants in the study told us that eTNS was easy to use at home and led, in some instances, to the best mental health they had experienced in years.  We expect these results, along with results from the remaining subjects in this Phase I trial, to form the basis for an upcoming Phase II clinical trial
'/>"/>

SOURCE NeuroSigma
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
2. Codexis Appoints Interim Chief Executive Officer
3. Savient Pharmaceuticals Appoints David Y. Norton Interim Chief Executive Officer
4. Quark Pharmaceuticals Reports Favorable Interim Results from Phase I Clinical Study of QPI-1007 in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
5. Breast Cancer Vaccine Reduces Cancer Recurrence in Women: Interim Results From Phase 2 Clinical Trial Trend Toward AE37 Vaccine Benefit; Results Presented at SABCS
6. Golden Meditech FY2011-12 Interim Results
7. Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheims Two Investigational HCV Direct Acting Antivirals Presented at AASLD
8. Interim Data Announced for BIBF 1120 as Compared to bevacizumab in Combination Chemotherapy in Metastatic Colorectal Cancer
9. Dr. Eva Feldman, Principal Investigator, Presents Interim Data on Neuralstem ALS Trial
10. Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339
11. Landauer Elects Board Member Michael T. Leatherman as Interim Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 2013 Velplex, LLC announced this week that ... that connects buyers and sellers of discount dental ... Why? It,s because the business leaders ... with the dental industry. They have 50 years of ... worked to negotiate some of the best prices in ...
(Date:6/17/2013)... , June 17, 2013 Vanda ... presented additional data today at ENDO 2013, the ... that tasimelteon can entrain (synchronize) both melatonin and ... to reset the master body clock and address ... Disorder (Non-24).  The SET (Safety and Efficacy of ...
(Date:6/17/2013)...  Hanger, Inc. (NYSE:  HGR) today announced the signing ... senior secured facilities to an aggregate of up to ... agreement includes a $200 million revolving credit facility and ... agreement was comprised of a $100 million revolving credit ... facility matures on June 17, 2018, and is subject ...
Breaking Medicine Technology:TopProdeals.com Rises to Top as Discount Dental Supply Leader 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 2Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 3
... 2011 Watson Pharmaceuticals, Inc. (NYSE: ... has received U.S. Food and Drug Administration ("FDA") ... for Enoxaparin Sodium Injection in the 100mg/mL and ... equivalent to Sanofi-aventis, LOVENOX®, and is a low ...
... SYDNEY, Sept. 19, 2011 HeartWare International, Inc. (NASDAQ: ... innovator of less invasive, miniaturized circulatory support technologies that ... announced that CEO Doug Godshall is scheduled to present ... Device Day at 1:55 p.m. ET on Thursday, September ...
Cached Medicine Technology:Watson Pharmaceuticals Announces Approval of Amphastar's Generic LOVENOX(R) 2Watson Pharmaceuticals Announces Approval of Amphastar's Generic LOVENOX(R) 3HeartWare to Present at The Lazard Capital Markets 3rd Annual Circulatory Assist Device Day 2
(Date:6/17/2013)... Cell Institute (HSCI) researchers have identified in the most ... embryonic stem cell self-renewal, beginning a creative search for ... gene, SALL4, gives stem cells their ability to continue ... Typically, cells only express SALL4 during embryonic development, but ... acute myeloid leukemia and 10 to 30 percent of ...
(Date:6/17/2013)... The Woodstock Fruit Festival is proud to extend an ... which will be held in Diamond Point, New York from ... professes the benefits he's received by regularly eating up ... class sprinting abilities. Fruit is commonly considered health food, but ... Blake believes in the power of natural foods, and the ...
(Date:6/17/2013)... 2013 MelanSol® All Natural Skin Care ... the US distributor for MelanSol®, has partnered with the ... Food Bank to support their efforts to feed ... that they receive a portion of every sale of ... Moisturizer. Contributions will be given on sales from ...
(Date:6/17/2013)... YORK, NY (June 17, 2013) A team from ... and the Naomi Berrie Diabetes Center of Columbia University ... accurately reflect the features of maturity-onset diabetes of the ... of MODY patients to produce induced pluripotent stem (iPS) ... into a mouse, the stem cell-derived beta cells secreted ...
(Date:6/17/2013)... Tarrant Plastic Surgery is pleased to announce a summer mommy ... undergone a mainstream culture explosion. Interpretation of the term may ... regard the term to mean a combination of breast and ... effects of pregnancy on a woman’s body. , Effects ... with gain or loss of volume, widening of the nipple ...
Breaking Medicine News(10 mins):Health News:A new target for cancer drug development 2Health News:Yohan Blake Invited to The Woodstock Fruit Festival as Guest of Honor 2Health News:All Natural Sunscreen Fights Hunger 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 3Health News:Tarrant Plastic Surgery Announces Summer Makeover Special 2
... Boston Scientific Corporation (NYSE: BSX ) ... Company 29th Annual Health Care Conference.Jim Tobin, Chief Executive ... 17th, beginning at approximately 3:55 p.m. E.T. Following ... Financial Officer will join Mr. Tobin in a question ...
... 10 Representatives Gene Green (D-TX), Ed Whitfield (R-KY), ... Mike Rogers (R-MI), Betty Sutton (D-OH), Bart Gordon (D-TN), ... H.R. 1392. This bill will amend title XVIII of ... amounts for drugs and biologicals under Part B of ...
... , , GEORGETOWN, Texas, March 10 ... provider, ranked 21st overall in the recent Dun & ... Clips is listed as the highest-ranked, fastest-growing hair-care franchise ... AllBusiness.com "Top 10 Franchises for Veterans." ...
... Coronado, Washington Four Seasons and seven additional hotels join ... Luxury hotel owner, Strategic Hotels, today announced that ... UNICEF-supported clean water campaign known as the Tap ... award-winning, lifesaving initiative helps UNICEF provide clean water to ...
... are highlights from the March issue of Mayo ... as often as you wish. Mayo Clinic ... Reprinting is allowed for a fee. Include the following ... www.bookstore.mayoclinic.com or call toll-free for subscription information, 800-876-8633, ...
... Ltd. announced today that OAD Orthopaedics of Warrenville, Illinois, has ... is designed to save precious clinical time for busy ... seeing large volumes of patients each day. When a ... a reader, and the images for that patient are instantly ...
Cached Medicine News:Health News:House Bill to Improve Accuracy of Medicare Reimbursement Introduced: Members of Congress Seek to Stem Growing Healthcare Coverage Shortfalls, Community Oncology Alliance Advocates for Swift Passage of Bill 2Health News:House Bill to Improve Accuracy of Medicare Reimbursement Introduced: Members of Congress Seek to Stem Growing Healthcare Coverage Shortfalls, Community Oncology Alliance Advocates for Swift Passage of Bill 3Health News:Sport Clips Tops Hair-care Franchises in '2009 AllBusiness AllStars' 2Health News:Tap Project Partners With Strategic Hotels for 2009 UNICEF Clean Water Campaign 2Health News:Tap Project Partners With Strategic Hotels for 2009 UNICEF Clean Water Campaign 3Health News:March 2009 Mayo Clinic Women's HealthSource Highlights Molecular Breast Imaging, Canes and Walkers, Training for an Event and Hormone Therapy for Women 2Health News:March 2009 Mayo Clinic Women's HealthSource Highlights Molecular Breast Imaging, Canes and Walkers, Training for an Event and Hormone Therapy for Women 3Health News:March 2009 Mayo Clinic Women's HealthSource Highlights Molecular Breast Imaging, Canes and Walkers, Training for an Event and Hormone Therapy for Women 4Health News:March 2009 Mayo Clinic Women's HealthSource Highlights Molecular Breast Imaging, Canes and Walkers, Training for an Event and Hormone Therapy for Women 5Health News:March 2009 Mayo Clinic Women's HealthSource Highlights Molecular Breast Imaging, Canes and Walkers, Training for an Event and Hormone Therapy for Women 6Health News:'Swipe Card, See Image': OAD Orthopaedics Improves Clinical Workflow with OrthoFlow 2
... The model 55S Rocking Shaker provides ... and blotted membranes. The very slow ... degree of tilt provide a gentle ... over gels and blotted membranes to ...
Plate Roller...
Conversion Kits For Modular Incubator Chamber...
Multi-Tier Shaker...
Medicine Products: